Drug Shrinks Lung Cancer Tumors In Mice

One in five people with lung cancer have small cell lung cancer and only three per cent of these people are expected to survive for five years. With this form of lung cancer, tumours spread quickly so it is rarely possible to remove the tumours surgically. Because of this, small cell lung cancer is treated with chemotherapy, with or without additional radiotherapy. Initially, the treatment often appears to work, reducing the size of the tumours. However, the tumours usually grow back rapidly and then become resistant to further treatment.

The researchers behind today’s study have identified a drug that, in some mice, was able to completely shrink tumours away. In the mouse models, it was also able to stop tumours from growing and it helped other forms of chemotherapy to work more effectively. If the drug proves successful in humans, the researchers hope that it could help patients with this kind of lung cancer to live longer.

» Read more: Drug Shrinks Lung Cancer Tumors In Mice

Related posts

Beringer Vineyards helps fight childhood cancer

Beringer Vineyards helps fight childhood cancer
Saturday update Beringer Vineyards, the oldest continuously operating winery in Napa Valley, has joined forces with St. Jude Children’s Research Hospital in the fight against childhood cancer as the exclusive wine sponsor for the first annual star-studded Estrellas por la Vida (Stars for Life) gala fundraiser.

Read more on The St. Helena Star

Related posts

Markers for Ovarian Cancer May Show Up Years Earlier

Markers for Ovarian Cancer May Show Up Years Earlier
TUESDAY, Jan. 5 (HealthDay News) — Concentrations of several biomarkers begin to grow three years before women are diagnosed with ovarian cancer, but only reach substantial elevation levels over the 12 months before diagnosis, new research finds.

Read more on HealthDay via Yahoo! News

Related posts